cyclosporine and Syncope

cyclosporine has been researched along with Syncope in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanno, K; Murakami, A; Oda, F; Sayama, K; Sonobe, N; Tohyama, M1
Lehtoranta, K; Leppilahti, M; Multanen, M; Paananen, I; Ruutu, M; Sairanen, J; Tammela, TL1
Fujii, S; Hasegawa, T; Hosoi, M; Ishii, T; Miyamoto, M; Mori, T; Sato, T; Tanaka, S; Yamakita, T; Yamamoto, T; Yoshioka, K1

Trials

1 trial(s) available for cyclosporine and Syncope

ArticleYear
Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.
    The Journal of urology, 2005, Volume: 174, Issue:6

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Cystitis, Interstitial; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Pentosan Sulfuric Polyester; Prospective Studies; Syncope; Treatment Outcome

2005

Other Studies

2 other study(ies) available for cyclosporine and Syncope

ArticleYear
Bromoderma mimicking pyoderma gangrenosum caused by commercial sedatives.
    The Journal of dermatology, 2016, Volume: 43, Issue:5

    Topics: Acid-Base Equilibrium; Adult; Anorexia Nervosa; Biopsy; Bromides; Bromisovalum; Chlorides; Cyclosporine; Dermatologic Agents; Drug Eruptions; Erythema; Female; Glucocorticoids; Humans; Hypnotics and Sedatives; Nonprescription Drugs; Prednisolone; Pyoderma Gangrenosum; Rare Diseases; Seizures; Syncope; Withholding Treatment

2016
Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.
    Diabetes research and clinical practice, 2000, Volume: 49, Issue:1

    Topics: Aged; Autoantibodies; Blood Glucose; C-Peptide; Cyclophosphamide; Cyclosporine; Desensitization, Immunologic; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Immunosuppressive Agents; Insulin Resistance; Insulin-Like Growth Factor I; Male; Plasma Exchange; Plasmapheresis; Receptor, Insulin; Syncope

2000